Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

The U.S. Centers for Disease Control and Prevention (CDC) updated its guidance last week to recommend measles-mumps-rubella ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

Investigators assessed which aspects of surgical performance during radical prostatectomy improve the chances of good functional outcomes.

In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9 percent with early and late discontinuation and nondiscontinuation, respectively.

(HealthDay News) — Medical school attrition rates are high among lesbian, gay, or bisexual (LGB) medical students, according to a research letter published online June 10 in JAMA Network Open.

(HealthDay News) — From 2013 to 2023, there was an increase in the proportion of U.S. adults who were unaware of having hypertension, according to a research letter published online June 4 in JAMA ...

The histopathologic features of eosinophilic angiocentric fibrosis overlap with IgG4-RD and AAV, making diagnosis difficult.

(HealthDay News) — The artificial sweetener neotame is ubiquitous in popular disposable e-cigarettes, according to a research letter published online June 2 in the Journal of the American Medical ...

The FDA has approved Nubeqa (darolutamide), an androgen receptor inhibitor, for the treatment of mCSPC in adults.

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

The median time to treatment initiation is increasing across cancer types, and this appears to be driven by an increase in stage I cancer diagnoses, data suggest.